drugset / Trial / NCT00885079

Confirmatory Study of OPC-12759 Ophthalmic Suspension

NCT00885079

Phase 3 Completed 188 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to verify whether OPC-12759 ophthalmic suspension is effective compared with active control in dry eye patients.

Timeline

Start
2009-05
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Rebamipide Small molecule 2 % Topical
Comparator Sodium Hyaluronate Other / unclassified 0.1 % Topical

Indications